Literature DB >> 8593178

Activities of antioxidant enzymes and formation of the glutathione adduct of hemoglobin (Hb ASSG) in epileptic patients with long-term antiepileptic therapy.

V Niketić1, S Ristić, Z S Saicić, M Spasić, B Buzadzić, M Stojković.   

Abstract

The activities of antioxidant enzymes (AOE) and amounts of glutathione adduct of Hb (Hb ASSG) in erythrocytes of chronic epileptic patients treated with mono or mixed therapy of phenobarbital (PB), carbamazepin (CBZ) and valproic acid (VPA), were evaluated and the results were compared with those for normal individuals. The activity of superoxide dismutase (SOD) was lowered for 40% to 60% in epileptic patients relative to normal controls. The lowest activity of SOD was found in patients treated with CBZ and PB. Activity of glutathione peroxidase (GSH-Px) was lowered comparing to the control from cca 15% in patients treated with PB to 50% in those treated with either CBZ alone or with CBZ in combination with PB. For the later two sub-groups of patients significantly lowered activities of catalase and glutathione reductase (cca 20% and 30-40%, respectively) were also characteristic. The highest amounts of Hb ASSG (cca 4% of the tota lHb) were found in hemolysates of patients with the lowest AOE levels i.e., in those treated with CBZ alone or with CBZ in combination with PB. In hemolysates of patients treated with PB, Hb ASSG represented 2.4% of the total Hb, while it was totally absent in those treated with VPA, although SOD and GSH-Px levels in erythrocytes of both of these sub-groups of patients were lowered to the same extent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8593178

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  8 in total

Review 1.  Role of oxidative stress in epileptic seizures.

Authors:  Eun-Joo Shin; Ji Hoon Jeong; Yoon Hee Chung; Won-Ki Kim; Kwang-Ho Ko; Jae-Hyung Bach; Jau-Shyong Hong; Yukio Yoneda; Hyoung-Chun Kim
Journal:  Neurochem Int       Date:  2011-06-13       Impact factor: 3.921

2.  Antioxidants as a preventive treatment for epileptic process: a review of the current status.

Authors:  Boštjan Martinc; Iztok Grabnar; Tomaž Vovk
Journal:  Curr Neuropharmacol       Date:  2014-12       Impact factor: 7.363

3.  Low plasma antioxidant status in patients with epilepsy and the role of antiepileptic drugs on oxidative stress.

Authors:  Bindu Menon; Krishnan Ramalingam; Rajendiran Vinoth Kumar
Journal:  Ann Indian Acad Neurol       Date:  2014-10       Impact factor: 1.383

Review 4.  Relevance of the glutathione system in temporal lobe epilepsy: evidence in human and experimental models.

Authors:  Noemí Cárdenas-Rodríguez; Elvia Coballase-Urrutia; Claudia Pérez-Cruz; Hortencia Montesinos-Correa; Liliana Rivera-Espinosa; Aristides Sampieri; Liliana Carmona-Aparicio
Journal:  Oxid Med Cell Longev       Date:  2014-11-30       Impact factor: 6.543

5.  Effect of levetiracetam drug on antioxidant and liver enzymes in epileptic patients: case-control study.

Authors:  Atena Mahdavi; Amirmansour Alavi Naeini; Mohammadreza Najafi; Mohammadreza Maracy; Mohammadreza Aghaye Ghazvini
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

6.  Oxidative stress is increased in women with epilepsy: Is it a potential mechanism of anti-epileptic drug-induced teratogenesis?

Authors:  Damayanthi Deepa; Narayani Jayakumari; Sanjeev V Thomas
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

7.  The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress.

Authors:  Boštjan Martinc; Iztok Grabnar; Tomaž Vovk
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

8.  Oxidative Status in Epileptic Children Using Carbamazepine.

Authors:  Murat Tutanc; Mustafa Aras; Recep Dokuyucu; Murat Altas; Cem Zeren; Vefik Arica; Oktay Hasan Ozturk; Sedat Motor; Cahide Yilmaz
Journal:  Iran J Pediatr       Date:  2015-12-23       Impact factor: 0.364

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.